ContributorsPublishersAdvertisers

Treatment Paradigm for R/R Multiple Myeloma Continues to Expand

targetedonc.com
 2021-10-15

Cover picture for the articleDuring the NCCN 2021 Congress: Hematologic Malignancies Natalie S. Callander, MD, discusses treatment options in relapsed/refractory multiple myeloma. While initial disease control in multiple myeloma has improved, relapse is almost always inevitable. However, there are many treatment options available for this patient population, according to a presentation at the NCCN 2021...

www.targetedonc.com

Comments / 0

Comments / 0